Rankings
▼
Calendar
PLSE FY 2022 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
PLSE
Pulse Biosciences, Inc.
$1B
FY 2022 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$700,000
-50.6% YoY
Gross Profit
-$11M
-1606.3% margin
Operating Income
-$58M
-8293.9% margin
Net Income
-$59M
-8357.9% margin
EPS (Diluted)
$-1.72
Cash Flow
Operating Cash Flow
-$47M
Free Cash Flow
-$47M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$78M
Total Liabilities
$80M
Stockholders' Equity
-$2M
Cash & Equivalents
$61M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$700,000
$1M
-50.6%
Gross Profit
-$11M
-$550,000
-1944.4%
Operating Income
-$58M
-$63M
+7.9%
Net Income
-$59M
-$64M
+8.1%
← Q4 2021
All Quarters
Q1 2022 →